Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

dc.contributor.author

Haugen, Astrid C

dc.contributor.author

Di Prospero, Nicholas A

dc.contributor.author

Parker, Joel S

dc.contributor.author

Fannin, Rick D

dc.contributor.author

Chou, Jeff

dc.contributor.author

Meyer, Joel N

dc.contributor.author

Halweg, Christopher

dc.contributor.author

Collins, Jennifer B

dc.contributor.author

Durr, Alexandra

dc.contributor.author

Fischbeck, Kenneth

dc.contributor.author

Van Houten, Bennett

dc.contributor.editor

Pearson, Christopher E

dc.coverage.spatial

United States

dc.date.accessioned

2011-06-21T17:31:16Z

dc.date.issued

2010-01-15

dc.description.abstract

The neurodegenerative disease Friedreich's ataxia (FRDA) is the most common autosomal-recessively inherited ataxia and is caused by a GAA triplet repeat expansion in the first intron of the frataxin gene. In this disease, transcription of frataxin, a mitochondrial protein involved in iron homeostasis, is impaired, resulting in a significant reduction in mRNA and protein levels. Global gene expression analysis was performed in peripheral blood samples from FRDA patients as compared to controls, which suggested altered expression patterns pertaining to genotoxic stress. We then confirmed the presence of genotoxic DNA damage by using a gene-specific quantitative PCR assay and discovered an increase in both mitochondrial and nuclear DNA damage in the blood of these patients (p<0.0001, respectively). Additionally, frataxin mRNA levels correlated with age of onset of disease and displayed unique sets of gene alterations involved in immune response, oxidative phosphorylation, and protein synthesis. Many of the key pathways observed by transcription profiling were downregulated, and we believe these data suggest that patients with prolonged frataxin deficiency undergo a systemic survival response to chronic genotoxic stress and consequent DNA damage detectable in blood. In conclusion, our results yield insight into the nature and progression of FRDA, as well as possible therapeutic approaches. Furthermore, the identification of potential biomarkers, including the DNA damage found in peripheral blood, may have predictive value in future clinical trials.

dc.description.version

Version of Record

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/20090835

dc.identifier.eissn

1553-7404

dc.identifier.uri

https://hdl.handle.net/10161/4460

dc.language

eng

dc.language.iso

en_US

dc.publisher

Public Library of Science (PLoS)

dc.relation.ispartof

PLoS Genet

dc.relation.isversionof

10.1371/journal.pgen.1000812

dc.relation.journal

Plos Genetics

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Cells, Cultured

dc.subject

Child

dc.subject

Cohort Studies

dc.subject

DNA Damage

dc.subject

Female

dc.subject

Friedreich Ataxia

dc.subject

Gene Expression

dc.subject

Humans

dc.subject

Iron-Binding Proteins

dc.subject

Male

dc.subject

Middle Aged

dc.subject

RNA

dc.subject

Young Adult

dc.title

Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

dc.title.alternative
dc.type

Journal article

duke.contributor.orcid

Meyer, Joel N|0000-0003-1219-0983

duke.date.pubdate

2010-1-0

duke.description.issue

1

duke.description.volume

6

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/20090835

pubs.begin-page

e1000812

pubs.issue

1

pubs.organisational-group

Civil and Environmental Engineering

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Environmental Sciences and Policy

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Nicholas School of the Environment

pubs.organisational-group

Pratt School of Engineering

pubs.organisational-group

School of Medicine

pubs.publication-status

Published online

pubs.volume

6

Files